BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 35323449)

  • 21. Utilizing Electrochemical-Based Sensing Approaches for the Detection of SARS-CoV-2 in Clinical Samples: A Review.
    Zambry NS; Obande GA; Khalid MF; Bustami Y; Hamzah HH; Awang MS; Aziah I; Manaf AA
    Biosensors (Basel); 2022 Jun; 12(7):. PubMed ID: 35884276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis.
    Galanis P; Vraka I; Fragkou D; Bilali A; Kaitelidou D
    J Hosp Infect; 2021 Feb; 108():120-134. PubMed ID: 33212126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Remote Fingerstick Blood Collection for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Testing.
    Garcia-Beltran WF; Miller TE; Kirkpatrick G; Nixon A; Astudillo MG; Yang D; Mahanta LM; Murali M; Dighe AS; Lennerz J; Thierauf J; Naranbhai V; Iafrate AJ
    Arch Pathol Lab Med; 2021 Apr; 145(4):415-418. PubMed ID: 33264390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seroprevalence Surveys for Anti-SARS-CoV-2 Antibody in Different Populations in Taiwan With Low Incidence of COVID-19 in 2020 and Severe Outbreaks of SARS in 2003.
    Tseng WP; Wu JL; Wu CC; Kuo KT; Lin CH; Chung MY; Lee YF; Yang BJ; Huang CH; Chen SY; Yu CJ; Chen SC; Hsueh PR
    Front Immunol; 2021; 12():626609. PubMed ID: 34084161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Applications of separation technology in novel coronavirus research, epidemic prevention and detection].
    Li L; Zhu C; Zhao X; Qu F
    Se Pu; 2021 Jul; 39(7):679-685. PubMed ID: 34227364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A high-throughput microfluidic nanoimmunoassay for detecting anti-SARS-CoV-2 antibodies in serum or ultralow-volume blood samples.
    Swank Z; Michielin G; Yip HM; Cohen P; Andrey DO; Vuilleumier N; Kaiser L; Eckerle I; Meyer B; Maerkl SJ
    Proc Natl Acad Sci U S A; 2021 May; 118(18):. PubMed ID: 33945500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Future developments in biosensors for field-ready SARS-CoV-2 virus diagnostics.
    Fani M; Zandi M; Soltani S; Abbasi S
    Biotechnol Appl Biochem; 2021 Aug; 68(4):695-699. PubMed ID: 32970352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in laboratory detection methods and technology application of SARS-CoV-2.
    Zhang X; Meng H; Liu H; Ye Q
    J Med Virol; 2022 Apr; 94(4):1357-1365. PubMed ID: 34854101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Point-of-Care Diagnostics of COVID-19: From Current Work to Future Perspectives.
    Hussein HA; Hassan RYA; Chino M; Febbraio F
    Sensors (Basel); 2020 Jul; 20(15):. PubMed ID: 32752043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in the staff of a public school system in the midwestern United States.
    Lopez L; Nguyen T; Weber G; Kleimola K; Bereda M; Liu Y; Accorsi EK; Skates SJ; Santa Maria JP; Smith KR; Kalinich M
    PLoS One; 2021; 16(6):e0243676. PubMed ID: 34111144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Second Wave of SARS-CoV-2 Circulation-Antibody Detection in the Domestic Cat Population in Germany.
    Michelitsch A; Schön J; Hoffmann D; Beer M; Wernike K
    Viruses; 2021 May; 13(6):. PubMed ID: 34072254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2 Point-of-Care (POC) Diagnosis Based on Commercial Pregnancy Test Strips and a Palm-Size Microfluidic Device.
    Yang M; Tang Y; Qi L; Zhang S; Liu Y; Lu B; Yu J; Zhu K; Li B; Du Y
    Anal Chem; 2021 Sep; 93(35):11956-11964. PubMed ID: 34424659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological characteristics and biomarkers of novel SARS-CoV-2 facilitated rapid development and implementation of diagnostic tools and surveillance measures.
    Ghodake GS; Shinde SK; Kadam AA; Saratale RG; Saratale GD; Syed A; Elgorban AM; Marraiki N; Kim DY
    Biosens Bioelectron; 2021 Apr; 177():112969. PubMed ID: 33434780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020.
    Shakiba M; Nazemipour M; Salari A; Mehrabian F; Nazari SSH; Rezvani SM; Ghasempour Z; Heidarzadeh A; Mansournia MA
    Emerg Infect Dis; 2021 Feb; 27(2):636-638. PubMed ID: 33349310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High SARS-CoV-2 Seroprevalence in Rural Peru, 2021: a Cross-Sectional Population-Based Study.
    Moreira-Soto A; Pachamora Diaz JM; González-Auza L; Merino Merino XJ; Schwalb A; Drosten C; Gotuzzo E; Talledo M; Arévalo Ramirez H; Peralta Delgado R; Bocanegra Vargas S; Drexler JF
    mSphere; 2021 Dec; 6(6):e0068521. PubMed ID: 34817236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a SARS-CoV-2-specific biosensor for antigen detection using scFv-Fc fusion proteins.
    Kim HY; Lee JH; Kim MJ; Park SC; Choi M; Lee W; Ku KB; Kim BT; Changkyun Park E; Kim HG; Kim SI
    Biosens Bioelectron; 2021 Mar; 175():112868. PubMed ID: 33281048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of SARS-CoV-2-Specific Antibodies, Japan, June 2020.
    Yoshiyama T; Saito Y; Masuda K; Nakanishi Y; Kido Y; Uchimura K; Mitarai S; Suzuki T; Nakagama Y; Kubota H; Satomi M; Uchikoba S; Ohnishi M; Wakita T; Kato S; Kato K
    Emerg Infect Dis; 2021 Feb; 27(2):628-631. PubMed ID: 33496235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IFCC interim guidelines on rapid point-of-care antigen testing for SARS-CoV-2 detection in asymptomatic and symptomatic individuals.
    Bohn MK; Lippi G; Horvath AR; Erasmus R; Grimmler M; Gramegna M; Mancini N; Mueller R; Rawlinson WD; Menezes ME; Patru MM; Rota F; Sethi S; Singh K; Yuen KY; Wang CB; Adeli K;
    Clin Chem Lab Med; 2021 Aug; 59(9):1507-1515. PubMed ID: 33908222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients.
    Luchsinger LL; Ransegnola BP; Jin DK; Muecksch F; Weisblum Y; Bao W; George PJ; Rodriguez M; Tricoche N; Schmidt F; Gao C; Jawahar S; Pal M; Schnall E; Zhang H; Strauss D; Yazdanbakhsh K; Hillyer CD; Bieniasz PD; Hatziioannou T
    J Clin Microbiol; 2020 Nov; 58(12):. PubMed ID: 32917729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seroprevalence of SARS-CoV-2 immunoglobulin antibodies in Wuhan, China: part of the city-wide massive testing campaign.
    Pan Y; Li X; Yang G; Fan J; Tang Y; Hong X; Guo S; Li J; Yao D; Cheng Z; Yuan Y; Li Y; Wang X
    Clin Microbiol Infect; 2021 Feb; 27(2):253-257. PubMed ID: 33035672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.